Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Neosulf Plus 250 mg Bolus is a Health Canada–registered veterinary drug (DIN 02065541) held by Citadel Animal Health, containing Neomycin (Neomycin Sulfate). Health Canada lists its status as Cancelled Post Market (status date 27 Jul 2018).

Health Canada registration

DIN02065541
Brand nameNeosulf Plus
Active ingredientNeomycin (Neomycin Sulfate)
Strength250 mg
Dosage formBolus
RouteOral
CompanyCitadel Animal Health
StatusCancelled Post Market — 27 Jul 2018
ClassVeterinary
ATC
AHFS84:80.00
Regulator recordHealth Canada DPD entry · Product monograph

Regulator price references for Neomycin (Neomycin Sulfate)

Published list or reimbursement prices for Neomycin (Neomycin Sulfate) presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.

CountryProductStrengthPackPriceTypeSourceAs of
CanadaOptimyxin Plus1.75mg10,000U/2.5MG/0.025MG PER ML EYE/EAR SOLUTION SOLUTION per unit0.73 CADreimbursementProvincial formulary SK2026-09-24
CanadaViaderm KC2.5mg2.5mg/0.25mg/1mg/gr Ointment Ointment per unit0.74 CADreimbursementProvincial formulary NL2026-09-24
CanadaCortisporin3.5mg1.41 CADreimbursementProvincial formulary BC2026-09-24

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Neosulf Plus (DIN 02065541) marketed in Canada?

No. Health Canada lists DIN 02065541 as Cancelled Post Market as of 27 Jul 2018.

Who holds the Canadian licence for this product?

Citadel Animal Health is the company of record in the Health Canada Drug Product Database.

Is the same medicine registered outside Canada?

No same-molecule registration has been matched in the 56 national registries Nexara Health tracks. Contact us to check manually.

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02065541, status date 2018-07-27; price sources: Provincial formulary BC, Provincial formulary NL, Provincial formulary SK. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02065541, status date 2018-07-27; price sources: Provincial formulary BC, Provincial formulary NL, Provincial formulary SK.

Health Canada Drug Product Database (DPD), DIN 02065541, status date 2018-07-27; price sources: Provincial formulary BC, Provincial formulary NL, Provincial formulary SK. Last reviewed 2026-09-28. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.